UNC Lineberger Comprehensive Cancer Center — CureCurrent

Published trials163

Recruiting shown33

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Pharmacologic Therapies to Mitigate Radiation- Associated Heart DiseaseNCT07685938 · lead sponsor · 2026-08-12

Effects of Infusion Timing on Treatment Response in Solid TumorsNCT07630168 · lead sponsor · 2026-08-03

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation OncologyNCT07463833 · lead sponsor · 2026-06-22

Tirzepatide in Obesity-Driven Endometrial CancerNCT07065552 · lead sponsor · 2026-04-27

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast CancerNCT07276880 · lead sponsor · 2026-03-17

PREDICT-RD: ctDNA Surveillance in TNBC With Residual DiseaseNCT07069595 · lead sponsor · 2026-02-26

Evolutionary Clinical Trial for Novel Biomarker-Driven TherapiesNCT07340541 · lead sponsor · 2026-02-16

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIVNCT07428330 · lead sponsor · 2026-02-03

Nutrition Awareness Among Women With Non-Metastatic Breast CancerNCT07389967 · lead sponsor · 2026-01-20

Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase ExerciseNCT07313306 · lead sponsor · 2025-12-15

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) ImagingNCT07225114 · lead sponsor · 2025-11-04

Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer SurvivorsNCT06848491 · lead sponsor · 2025-10-27

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast CancerNCT07025785 · lead sponsor · 2025-08-22

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast CancerNCT06727773 · lead sponsor · 2025-08-19

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and DiabetesNCT07061652 · lead sponsor · 2025-07-03

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and SurvivalNCT06896162 · lead sponsor · 2025-06-27

Designing Visual Tools to Enhance Cancer Surgeon Decision-makingNCT06965192 · lead sponsor · 2025-04-24

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer PatientsNCT06878547 · lead sponsor · 2025-03-07

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)NCT06902311 · lead sponsor · 2025-02-19

Promoting Resilience in Women With Breast Cancer (PRISM -MBC)NCT06855654 · lead sponsor · 2025-01-01

A Novel Approach Utilizing Organ Specific Age ProteomicsNCT06789653 · lead sponsor · 2024-10-10

BREAST Choice Decision Tool R21 - AIM2NCT06817226 · lead sponsor · 2024-10-10

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T CellsNCT06347068 · lead sponsor · 2024-06-27

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer StudyNCT07214610 · lead sponsor · 2023-11-28

ONC201 and Atezolizumab in Obesity-Driven Endometrial CancerNCT05542407 · lead sponsor · 2023-10-23

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung CancerNCT05620342 · lead sponsor · 2023-06-21

Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South AfricaNCT05413798 · lead sponsor · 2023-05-11

Study of Trilaciclib and LurbinectidinNCT05578326 · lead sponsor · 2022-10-12

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among CliniciansNCT05440929 · lead sponsor · 2022-07-07

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After LumpectomyNCT05472792 · lead sponsor · 2022-05-17

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCANCT03769415 · lead sponsor · 2018-11-06

UNC Pleural Fluid RegistryNCT05620329 · lead sponsor · 2018-01-24

Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorNCT01000883 · lead sponsor · 1998-12-01

Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With PembrolizumabNCT04266730 · lead sponsor · 2027-05-20

Optimization of Dietary Adherence in a Mobile Weight Loss InterventionNCT07582536 · lead sponsor · 2027-03-01

NOT_YET_RECRUITING

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial CancerNCT07078838 · lead sponsor · 2027-01-01

NOT_YET_RECRUITING

Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLCNCT07639242 · lead sponsor · 2026-10-01

C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United StatesNCT07520188 · lead sponsor · 2026-09-10

NOT_YET_RECRUITING

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIVNCT07624123 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in KenyaNCT07545746 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down SyndromeNCT07296861 · lead sponsor · 2026-04-16

ACTIVE_NOT_RECRUITING

Dissemination of BREASTChoice AIM1-BNCT07396766 · lead sponsor · 2025-10-01

Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive InterventionsNCT05751993 · lead sponsor · 2025-04-12

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in KenyaNCT06519994 · lead sponsor · 2025-01-22

VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control SubjectsNCT06547034 · lead sponsor · 2024-10-16

Abequolixron (RGX-104) and Durvalumab in Lung CancerNCT05911308 · lead sponsor · 2024-04-01

Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsNCT06171945 · lead sponsor · 2024-03-01

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer TreatmentNCT06096623 · lead sponsor · 2023-11-06

5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East AfricaNCT05362955 · lead sponsor · 2023-04-26

Kaposi Sarcoma Chemotherapy and Research (KS-CARE)NCT06480773 · lead sponsor · 2023-04-25

ACTIVE_NOT_RECRUITING

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIVNCT05413811 · lead sponsor · 2023-03-22

Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast CancerNCT05755347 · lead sponsor · 2023-03-17

Risk Stratification for Patients With Hospital-diagnosed Advanced Lung CancerNCT05722847 · lead sponsor · 2023-03-14

Comparison of CE-DBT and MRI in Patients With Known Breast LesionsNCT05754749 · lead sponsor · 2023-03-13

Evaluation of Child Care Staff Weight Management ProgramNCT05656807 · lead sponsor · 2023-01-18

ACTIVE_NOT_RECRUITING

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary TreatmentNCT05926024 · lead sponsor · 2023-01-06

ACTIVE_NOT_RECRUITING

Adaptation of a Values Assessment ToolNCT07068477 · lead sponsor · 2023-01-05

PSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerNCT04243941 · lead sponsor · 2022-11-29

Physical Function During ARSI TreatmentNCT05612880 · lead sponsor · 2022-10-13

Metastatic Breast Cancer-Specific Prognostic ToolNCT05574478 · lead sponsor · 2022-09-20

Sponsor roles

lead sponsor157

collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.